Clinical Study Grants
Funds ambitious, practice-changing clinical trials and major observational studies in cardiovascular medicine to advance patient care and inform future research.
Funder: British Heart Foundation
Due Dates: January 14, 2026 (Full) | July 1, 2026 (Full) | February 5, 2026 (Prelim) | April 23, 2026 (Prelim) | August 27, 2026 (Prelim) | October 22, 2026 (Prelim)
Funding Amounts: No formal cap; awards typically >£500,000 or >4 years; duration usually 4–10 years; costs must match scale and ambition.
Summary: Supports ambitious, practice-changing clinical trials and major observational studies in cardiovascular medicine to advance patient care.
Key Information: Two-stage process: preliminary application required before full submission unless GCRFF-endorsed.
Description
This scheme funds large-scale, late-phase (phase III/IV) clinical trials and major hypothesis-led observational studies focused on defined clinical questions in cardiovascular medicine. Projects should aim to directly impact patient care or inform future clinical trials, with an emphasis on national or international collaboration and practice-changing potential. Studies must primarily recruit from NHS patient populations and may include mechanistic sub-studies. The British Heart Foundation (BHF) encourages applications that address key clinical priorities and demonstrate high scientific quality, feasibility, and value for money.
